752 related articles for article (PubMed ID: 16520299)
1. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
2. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.
Dodge T; Litt D; Kaufman A
J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738
[TBL] [Abstract][Full Text] [Related]
3. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
Jiang T
Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
[TBL] [Abstract][Full Text] [Related]
4. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
Dodge T; Kaufman A
Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
[TBL] [Abstract][Full Text] [Related]
5. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplements and lessons to be learned from GRAS.
Burdock GA
Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
[TBL] [Abstract][Full Text] [Related]
7. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
8. The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations.
Wollschlaeger B
Int J Toxicol; 2003; 22(5):387-90. PubMed ID: 14555412
[TBL] [Abstract][Full Text] [Related]
9. The Dietary Supplement Health and Education Act.
Young AL; Bass IS
Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
[No Abstract] [Full Text] [Related]
10. The Food and Drug Administration's actions on ephedra and androstenedione: understanding their potential impacts on the protections of the Dietary Supplement Health and Education Act.
Siegner AW
Food Drug Law J; 2004; 59(4):617-28. PubMed ID: 15880877
[No Abstract] [Full Text] [Related]
11. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
Woo JJ
Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
[No Abstract] [Full Text] [Related]
12. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
McNamara SH
Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
[No Abstract] [Full Text] [Related]
13. Premarket notifications of new dietary ingredients--a ten-year review.
McGuffin M; Young AL
Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394
[No Abstract] [Full Text] [Related]
14. Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Phillips GC
Curr Sports Med Rep; 2004 Aug; 3(4):224-8. PubMed ID: 15231227
[TBL] [Abstract][Full Text] [Related]
15. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
Silverglade BA
Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
[No Abstract] [Full Text] [Related]
16. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
Kaczka KA
J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
[No Abstract] [Full Text] [Related]
17. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
Foote JC
J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
[TBL] [Abstract][Full Text] [Related]
18. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
19. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
Melethil S
Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
[TBL] [Abstract][Full Text] [Related]
20. Assessing supplement safety--the FDA's controversial proposal.
Cohen PA
N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
